Bionano Genomics, Inc. (NASDAQ:BNGO - Get Free Report)'s stock price hit a new 52-week low on Monday . The company traded as low as $6.04 and last traded at $6.02, with a volume of 160997 shares traded. The stock had previously closed at $7.29.
Analysts Set New Price Targets
Separately, LADENBURG THALM/SH SH cut shares of Bionano Genomics from a "buy" rating to a "neutral" rating in a research note on Friday, November 15th.
Check Out Our Latest Research Report on Bionano Genomics
Bionano Genomics Stock Performance
The company has a market capitalization of $680.47 million, a P/E ratio of -2.51 and a beta of 2.22. The business has a 50 day moving average of $13.43 and a 200 day moving average of $21.79. The company has a quick ratio of 0.99, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.
Hedge Funds Weigh In On Bionano Genomics
A number of institutional investors and hedge funds have recently made changes to their positions in BNGO. Geode Capital Management LLC lifted its stake in shares of Bionano Genomics by 47.3% in the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company's stock valued at $401,000 after purchasing an additional 283,639 shares during the last quarter. GSA Capital Partners LLP bought a new stake in Bionano Genomics in the third quarter worth $46,000. Finally, Carret Asset Management LLC boosted its stake in Bionano Genomics by 89.0% during the third quarter. Carret Asset Management LLC now owns 85,055 shares of the company's stock worth $39,000 after buying an additional 40,055 shares during the period. 11.35% of the stock is owned by hedge funds and other institutional investors.
Bionano Genomics Company Profile
(
Get Free Report)
Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.
Featured Articles
Before you consider Bionano Genomics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bionano Genomics wasn't on the list.
While Bionano Genomics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
